Tampere University Hospital
Tampere, Pirkanmaa, Finland
NCT Number: NCT00490386
This study is performed to measure wether Helicobacter Pylori has an effect on the incidence and course of acute alcohol induced pancreatitis
Looking for future studies?
Notify MeAll sexes
Observational
Tampere, Pirkanmaa, Finland
A recent pilot study unexpectedly discovered, that Helicobacter pylori infection was rare in patients having their first acute alcohol induced pancreatitis (AAIP) when compared to subjects with similar alcohol use but no history of pancreatitis. This subject has not been studied in humans until now. Therefore we seek to study, with a larger material, wether AAIP is associated with lower prevalence of Helicobacter pylori, by measuring the antibodies against Helicobacter pylori from the sera of AAIP patients and from a control group of alcoholics with no history of AAIP.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tampere University
Other
Alkoholihaimatulehduksen Uusiminen
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03609944
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Little Rock, Arkansas, United States
View Trial DetailsNCT05381428
Digestive System Diseases, Pancreatic Diseases
Baggiovara, Modena, Italy
View Trial DetailsNCT06706440
Children, Digestive System Diseases
Moscow, Russia
View Trial DetailsNCT04570852
Digestive System Diseases, Pancreatic Diseases
Hvidovre, Capital, Denmark
View Trial Details